Literature DB >> 18194999

Sensitivity and specificity of computerized algorithms to classify gestational periods in the absence of information on date of conception.

Sengwee Toh1, Allen A Mitchell, Martha M Werler, Sonia Hernández-Díaz.   

Abstract

To evaluate the accuracy of computerized algorithms for pinpointing periods of exposure to medications during pregnancy in the absence of data on timing of conception, the authors used data from a population-based sample of nonmalformed infants in the Slone Epidemiology Center Birth Defects Study in 1998-2006 (United States and Canada; N = 3,177). The standard was defined as any antiinfective use from 2 weeks after the last menstrual period through the third gestational month, which was compared with results obtained after defining the beginning of pregnancy as either 270 days before the birth date (delivery-date algorithm) or the date of the first prenatal visit (pregnancy-indicator algorithm). The sensitivity was 92% (95% confidence interval: 88, 95) for the delivery-date algorithm and 59% (95% confidence interval: 53, 65) for the pregnancy-indicator algorithm. The specificity was higher than 98% for both algorithms. The sensitivity for the delivery-date algorithm among women with preterm births was 66% (95% confidence interval: 49, 80). For women without pregnancy complications, subtraction of 270 days from the delivery date might be accurate for timing first-trimester prescription drug use in automated databases. However, the sensitivity of this algorithm is lower for preterm deliveries, suggesting limited validity to assess drug safety for pregnancy outcomes associated with prematurity.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18194999     DOI: 10.1093/aje/kwm367

Source DB:  PubMed          Journal:  Am J Epidemiol        ISSN: 0002-9262            Impact factor:   4.897


  28 in total

Review 1.  Exposed or not exposed? Exploring exposure classification in studies using administrative data to investigate outcomes following medication use during pregnancy.

Authors:  Luke E Grzeskowiak; Andrew L Gilbert; Janna L Morrison
Journal:  Eur J Clin Pharmacol       Date:  2011-11-13       Impact factor: 2.953

2.  Selective serotonin reuptake inhibitor use and risk of gestational hypertension.

Authors:  Sengwee Toh; Allen A Mitchell; Carol Louik; Martha M Werler; Christina D Chambers; Sonia Hernández-Díaz
Journal:  Am J Psychiatry       Date:  2009-01-02       Impact factor: 18.112

3.  Proliferation of prenatal ultrasonography.

Authors:  John J You; David A Alter; Therese A Stukel; Sarah D McDonald; Andreas Laupacis; Ying Liu; Joel G Ray
Journal:  CMAJ       Date:  2010-01-04       Impact factor: 8.262

4.  Elevated risk of preeclampsia in pregnant women with depression: depression or antidepressants?

Authors:  Kristin Palmsten; Soko Setoguchi; Andrea V Margulis; Amanda R Patrick; Sonia Hernández-Díaz
Journal:  Am J Epidemiol       Date:  2012-03-22       Impact factor: 4.897

5.  Using insurance claims data to identify and estimate critical periods in pregnancy: An application to antidepressants.

Authors:  Elizabeth C Ailes; Regina M Simeone; April L Dawson; Emily E Petersen; Suzanne M Gilboa
Journal:  Birth Defects Res A Clin Mol Teratol       Date:  2016-11

6.  Antidepressant use during pregnancy and the risk of pregnancy-induced hypertension.

Authors:  Mary A De Vera; Anick Bérard
Journal:  Br J Clin Pharmacol       Date:  2012-08       Impact factor: 4.335

7.  Prevalence and trends in the use of antipsychotic medications during pregnancy in the U.S., 2001-2007: a population-based study of 585,615 deliveries.

Authors:  Sengwee Toh; Qian Li; T Craig Cheetham; William O Cooper; Robert L Davis; Sascha Dublin; Tarek A Hammad; De-Kun Li; Pamala A Pawloski; Simone P Pinheiro; Marsha A Raebel; Pamela E Scott; David H Smith; William V Bobo; Jean M Lawrence; Inna Dashevsky; Katherine Haffenreffer; Lyndsay A Avalos; Susan E Andrade
Journal:  Arch Womens Ment Health       Date:  2013-02-07       Impact factor: 3.633

8.  The prevalence and trends of antiviral medication use during pregnancy in the US: a population-based study of 664,297 deliveries in 2001-2007.

Authors:  Lyndsay A Avalos; Hong Chen; Chunmei Yang; Susan E Andrade; William O Cooper; Craig T Cheetham; Robert L Davis; Sascha Dublin; Tarek A Hammad; Sigal Kaplan; Pamala A Pawloski; Marsha A Raebel; Pamela E Scott; David H Smith; Sengwee Toh; De-Kun Li
Journal:  Matern Child Health J       Date:  2014-01

9.  Trends in the use of antiepileptic drugs among pregnant women in the US, 2001-2007: a medication exposure in pregnancy risk evaluation program study.

Authors:  William V Bobo; Robert L Davis; Sengwee Toh; De-Kun Li; Susan E Andrade; T Craig Cheetham; Pamala Pawloski; Sascha Dublin; Simone Pinheiro; Tarek Hammad; Pamela E Scott; Richard A Epstein; Patrick G Arbogast; James A Morrow; Judith A Dudley; Jean M Lawrence; Lyndsay A Avalos; William O Cooper
Journal:  Paediatr Perinat Epidemiol       Date:  2012-11       Impact factor: 3.980

10.  Validation of an algorithm to estimate gestational age in electronic health plan databases.

Authors:  Qian Li; Susan E Andrade; William O Cooper; Robert L Davis; Sascha Dublin; Tarek A Hammad; Pamala A Pawloski; Simone P Pinheiro; Marsha A Raebel; Pamela E Scott; David H Smith; Inna Dashevsky; Katherine Haffenreffer; Karin E Johnson; Sengwee Toh
Journal:  Pharmacoepidemiol Drug Saf       Date:  2013-01-21       Impact factor: 2.890

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.